Prne
September 21st, 2009
DÜSSELDORF, Germany -
- Important Investments for Pharmaceutical Markets in the USA and Europe
The Gerresheimer Group expands its activities in the pharmaceutical plastic business with two strategically significant investments in the USA and Europe. This week the company is almost simultaneously opening a new research and development center for medical plastic systems in the USA as well as a new production center for pharmaceutical plastic packaging in Spain. “Plastics are increasingly gaining in importance within our highly specialized service portfolio for the international pharmaceutical industry,” Gerresheimer AG CEO Dr. Axel Herberg says. “The pharmaceutical plastic business has meanwhile become the division with the highest growth rate, which we are continuing to expand systematically. These are crucial investments in the Gerresheimer Group’s growth.”
The new technological center in Peachtree City (Georgia/USA) is opening up a new dimension for the Group’s flourishing business with American industrial clients from the pharmaceutical, diagnostics and medical technology industry. As a full service provider for medical plastic systems, Gerresheimer has upgraded the US location, which has until recently been limited to manufacturing, to become a comprehensively operating research, development and production center. In the American market the Group now has facilities at the front end of its customized serial production of entire product and process development comparable to those only available in Europe up to now. The product range in this field includes highly developed inhalation systems for the treatment of respiratory diseases as well as insulin pen systems, skin-prick aids and lancets for the diabetes sector, which is also growing steadily.
The newly opened plant in Masalavés in Spain (region of Valencia) is also highly significant with regard to the broad market of standardized pharmaceutical system packaging made of plastics. The plant is deemed to be the biggest production center of its kind in Southern Europe and is a significant strategic base for Gerresheimer there as well as in the Central European region. Pharmaceutical bottles and multifunctional dosage and closure systems, for example for eye drops, contact lens care products, nose sprays as well as tablets, are being produced there.
With the help of significant acquisitions, targeted investments and organic growth Gerresheimer has accelerated its plastics business during the past five years and developed it into an internationally leading market force. All in all, the company now possesses 15 locations in Europe, America and Asia in this sector. Both segments of the plastics division are continuing to attain above average growth rates. Accounting for a third of group sales, plastics have already become the largest growth area within the Gerresheimer Group.
About Gerresheimer
Gerresheimer employs around 10,000 people in 40 locations in Europe, America and Asia. In the financial year 2008, worldwide sales totaled EUR1.06bn. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterized by high technical and regulatory barriers.
Contact Press: Burkhard Lingenberg Director Corporate Communication & Marketing Phone +49-211-6181-250 Fax +49-211-6181-241 e-mail b.lingenberg@gerresheimer.com Contact Investor Relations: Anke Linnartz Director Corporate Investor Relations Phone +49-211-6181-314 Fax +49-211-6181-121 e-mail a.linnartz@gerresheimer.com
Source: Gerresheimer AG
Contact Press: Burkhard Lingenberg, Director Corporate Communication & Marketing, Phone +49-211-6181-250, Fax +49-211-6181-241, e-mail b.lingenberg at gerresheimer.com;
Contact Investor Relations: Anke Linnartz, Director Corporate Investor Relations, Phone +49-211-6181-314, Fax +49-211-6181-121, e-mail a.linnartz at gerresheimer.com
Filed under Business, Corporate Expansion, Health, Medical Equipment, Pharmaceuticals | Tags: Dusseldorf, Germany, Gerresheimer AG, Spain, United States of America | Comment Below
Related Press Releases Gerresheimer Holds its own in Difficult EnvironmentJuly 14th, 2009 DÜSSELDORF, Germany -
- Sales in the First Half of 2009 (Excluding Technical Plastics) at Prior Year Level
- Growth in the Pharma Business
- Sales Decline in the Cyclical Segments of Cosmetics and Laboratory Glassware
In the first half of 2009, Gerresheimer AG achieved sales at the prior year level despite the continuing worldwide economic crisis. This result was mainly attributable to sales growth for pharmaceutical packaging and systems, with which Gerresheimer today makes more than 70% of Group sales. Gerresheimer Sells Technical Plastics BusinessJune 30th, 2009 DUSSELDORF, Germany - Gerresheimer AG, a leading manufacturer of glass and plastic products for the pharma & life science industry, has sold its Technical Plastics operations, which are not part of the MDAX company's core business, to the FBH Group, Bad Soden, Germany. "Through the sale of the Technical Plastics segment Gerresheimer has - as formerly announced - taken a further step in its focus on the core business of pharma & life science," says Dr. PTI Recycling Systems Formed to Sell/Service Modular, Food-Grade rPET Production System GloballyJune 21st, 2009 HOLLAND, Ohio - A compact, modular system to produce food-grade, recycled polyethylene terephthalate (rPET) resin is now available globally. The system has been designed to cost-effectively address increased international rPET demand for blow molding, injection molding and thermoforming applications, by efficiently turning post-consumer PET containers into reusable food-grade resin. Plastinum Signs Sales ContractJune 1st, 2009 LOS ANGELES - Plastinum Polymer Technologies BV, an indirect majority-owned subsidiary of Plastinum Polymer Technologies Corp. (OTC Bulletin Board: PLNU - News), today announced that it has signed a sales contract with a Dutch manufacturer for the sale to the manufacturer of 2500-3600MT on an annual basis of Plastinum's recently developed Infinymer 49.0, a product made from post-consumer mixed plastic household waste. Gerresheimer Opens New High-Tech Production Facility for Pharma Glass in ChinaMay 28th, 2009 DUSSELDORF, Germany - Now Seven Plants in China
The Gerresheimer Group today opened a new plant for pharmaceutical glass packaging in China. The high-tech production facility constructed in Danyang (Jiangsu Province) covers 16,000 square meters. Standard & Poor's Confirms Rating for GerresheimerMay 11th, 2009 DUSSELDORF, Germany - The rating agency Standard & Poor's has today confirmed the current rating of BB+ for the Gerresheimer Group and continues to categorize the outlook as stable. The focus of the MDAX company on the pharma & life science industry is therefore assessed as positive and sustainable by the rating agency. Gerresheimer AG Expands its Management Board: Andreas Schutte Appointed as New MemberApril 29th, 2009 DUSSELDORF, Germany - Mr. Andreas Schutte (47) has been appointed to the Management Board of Gerresheimer AG with effect from May 1, 2009. 2008 a Record Year for GerresheimerApril 28th, 2009 DUSSELDORF, Germany - Strong Focus on the Markets of Pharma & Life Science
- Annual General Meeting Passes Dividend of EUR0.40 per Share
The Annual General Meeting of Gerresheimer AG today passed an unchanged dividend of EUR0.40 per share following the record year in 2008. The Company finished the financial year 2008 with record results. 'Topical Dermatological Product Development in the USA' Workshop to Be Held on June 4, 2009 in East Brunswick, New Jersey, USAApril 8th, 2009 PETALUMA, California - Featuring US experts in topical dermatological drug development
Dow Pharmaceutical Sciences, Inc. today announced that it will hold a 1-day workshop on "Topical Dermatological Product Development in the USA" June 4, 2009 at the Hilton East Brunswick, New Jersey. Gerresheimer Achieves Solid Growth in Core Markets - Outlook ConfirmedApril 1st, 2009 DUSSELDORF, Germany - Group Sales in the First Quarter of 2009 at Prior Year Level; Sales up Almost 3% in the Core Business Despite Difficult Market Environment
- Adjusted EBITDA Margin of 17.1% in the Core Business, Continued Operating Earnings Strength
- CEO Dr. Axel Herberg: "Despite the difficult overall economic environment we continue to aim for profitable sales growth of around 6% to 7% in our core business for 2009."
In the first quarter of 2009 (December 2008 to February 2009) Gerresheimer AG maintained its total sales figure of EUR237.3m (Q1 2008: EUR239.1m) almost at the prior year level despite the difficult overall situation in the world economy.
Related News GVK Biosciences announces appointment of Gerhard N. Mayr to its Board of DirectorsAugust 4th, 2009 HYDERABAD - GVK Biosciences (GVK BIO) today announced the appointment of Gerhard N. Mayr to its Board of Directors. NGO demands lifting of ban on plastic bags in DelhiFebruary 26th, 2009 NEW DELHI - With the Delhi government imposing a ban on plastic bags in the capital, an NGO Wednesday demanded lifting of the ban and launched an awareness campaign to highlight the benefits of plastic. Plastic Bag Awareness Forum launched a campaign to create awareness among the users that plastic bags are not harmful. West Pharmaceutical Services buys Plastef Investissements for undisclosed amountJuly 7th, 2009 West Pharmaceutical buys Plastef InvestissementsLIONVILLE, Pa. — Medical products maker West Pharmaceutical Services Inc. Plastic decomposes at sea, releasing potentially dangerous chemicals, report saysAugust 20th, 2009 Study says plastic decomposes at seaWASHINGTON — Environmentalists have long denounced plastic as a long-lasting pollutant that doesn't break down. A new study indicates that, in the oceans, plastic does decompose, but says that's not a good thing either. Report: P&G discussions on selling pharmaceutical business advancingJuly 22nd, 2009 P&G drug-business sale talks advance, reports sayCINCINNATI — Talks on a sale of Procter & Gamble Co.'s pharmaceutical business are reportedly advancing. The Wall Street Journal in Wednesday's editions cited unidentified people familiar with the matter who say several potential buyers include specialty drug maker Warner Chilcott Ltd., and private-equity firm Cerberus Capital Management LP, and that a possible sale price is some $3 billion. Phoenix Group Global expands brand ZuriApril 1st, 2009 NEW DELHI - Phoenix Group Global, the owners and promoters of luxury resorts and business hotels, Wednesday announced that all its existing properties will be brought under the Zuri Hotels and Resorts banner - the Group's flagship brand of luxury hotels launched in October 2008. Aditya Kamani, director, Phoenix Group Global, said: 'This decision of parting ways with Carlson has been a mutual one and can be viewed as a natural progression for us as a company that has been in the business of luxury hospitality for a decade. Belgium's Solvay sells its pharmaceutical business to Abbott Laboratories of US for $7.6 blnSeptember 30th, 2009 Solvay sells pharma division to Abbott for $7.6BBRUSSELS — Solvay, the Belgian chemical and pharmaceutical group, said Monday it has agreed to sell its entire pharmaceutical business to Abbott Laboratories of Abbott Park, Illinois, for euro5.2 billion ($7.6 billion). The American company already holds U.S. President Patil cautions plastic industry for harming environmentFebruary 3rd, 2009 NEW DELHI - President Pratibha Patil Wednesday urged plastic manufacturers to take adequate measures for waste management, as more than half of the plastic waste is causing harm to the environment. 'Plastics are chemically inert by nature, but it's a question of degradability which has attracted severe criticism on its applications all around,' Patil said after inaugurating the seventh International Plastics Exhibition and Conference, PlastIndia-2009, here Wednesday. Plastic bag tax leads to 85 percent drop in use in Hong KongJuly 9th, 2009 HONG KONG - Plastic bag use in Hong Kong has dropped by 85 percent in the first two days since the introduction of a 6 US cents tax on every bag, a survey released Thursday showed. The number of plastic bags handed out in 18 supermarkets during a peak shopping hour before and after the introduction of the ban fell from 2,742 to 403, the environmental group Greeners Action said. Par Pharmaceutical offering $150 million in mix of stock, warrantsJune 19th, 2009 Par announces mixed offering for $150 millionNEW YORK — Par Pharmaceutical Cos. said Friday it is selling up to $150 million in a mixed shelf offering and plans to use the proceeds for general corporate purposes.
|
|